• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

O型口蹄疫疫苗有效性的荟萃分析。

A meta-analysis on the effectiveness of serotype O foot-and-mouth disease vaccines.

作者信息

Jiao Jiao, Yang Haihua, Liang Zhenqi, Pan Yanhui, Yang Jiaxin, Zhang Wenli, Wu Peng

机构信息

College of Life Sciences, Shihezi University, Shihezi, China.

Ministry of Education Key Laboratory of Xinjiang Phytomedicine Resource Utilization, Shihezi, China.

出版信息

Sci Rep. 2025 May 2;15(1):15381. doi: 10.1038/s41598-025-99518-3.

DOI:10.1038/s41598-025-99518-3
PMID:40316620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12048582/
Abstract

Foot-and-mouth disease (FMD) is a highly contagious viral disease of domesticated animals that causes major economic losses globally. In this meta-analysis, 29 studies were evaluated using a random-effects model to analyze the efficacy of FMD vaccines. The quantifying heterogeneity between the groups was low (tau = 0.000, tau = 0.000, and I = 0.0% [0.0%; 24.6%]). The meta-analysis revealed that the inactivated vaccine provides the best protection among different vaccine types, with the following ranking from highest to lowest efficacy: inactivated vaccine > mRNA vaccine > E. coli vaccine > plant vaccine > recombinant virus vaccine > phage vaccine > synthesize vaccine > DNA vaccine > negative control. The findings revealed that the inactivated vaccine provides the best protection among the different types of vaccines. Based on these findings, we recommend using inactivated vaccines as controls in the development of novel vaccines, as they achieved the highest efficacy among all evaluated vaccine types.

摘要

口蹄疫(FMD)是一种家养动物的高度传染性病毒性疾病,在全球范围内造成重大经济损失。在这项荟萃分析中,使用随机效应模型评估了29项研究,以分析口蹄疫疫苗的疗效。组间量化异质性较低(tau = 0.000,tau = 0.000,I = 0.0% [0.0%;24.6%])。荟萃分析显示,在不同类型的疫苗中,灭活疫苗提供了最佳保护,疗效从高到低排序如下:灭活疫苗>mRNA疫苗>大肠杆菌疫苗>植物疫苗>重组病毒疫苗>噬菌体疫苗>合成疫苗>DNA疫苗>阴性对照。研究结果表明,灭活疫苗在不同类型的疫苗中提供了最佳保护。基于这些发现,我们建议在新型疫苗的研发中使用灭活疫苗作为对照,因为它们在所有评估的疫苗类型中疗效最高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442d/12048582/ffe12eeef327/41598_2025_99518_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442d/12048582/5acf57cfe079/41598_2025_99518_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442d/12048582/a596a8fb4e2f/41598_2025_99518_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442d/12048582/c03be41cc9c5/41598_2025_99518_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442d/12048582/b137fa1dd40d/41598_2025_99518_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442d/12048582/ffe12eeef327/41598_2025_99518_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442d/12048582/5acf57cfe079/41598_2025_99518_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442d/12048582/a596a8fb4e2f/41598_2025_99518_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442d/12048582/c03be41cc9c5/41598_2025_99518_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442d/12048582/b137fa1dd40d/41598_2025_99518_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442d/12048582/ffe12eeef327/41598_2025_99518_Fig5_HTML.jpg

相似文献

1
A meta-analysis on the effectiveness of serotype O foot-and-mouth disease vaccines.O型口蹄疫疫苗有效性的荟萃分析。
Sci Rep. 2025 May 2;15(1):15381. doi: 10.1038/s41598-025-99518-3.
2
Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.工程化A型口蹄疫病毒疫苗对猪体内两种大流行毒株的交叉保护效力
Vaccine. 2015 Oct 26;33(43):5772-5778. doi: 10.1016/j.vaccine.2015.09.055. Epub 2015 Oct 1.
3
Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation.热荧光PaSTRy技术在改进口蹄疫病毒疫苗配方中的应用。
J Gen Virol. 2016 Jul;97(7):1557-1565. doi: 10.1099/jgv.0.000462. Epub 2016 Mar 22.
4
Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.口蹄疫疫苗及攻击病毒的快速工程制作
J Virol. 2017 Jul 27;91(16). doi: 10.1128/JVI.00155-17. Print 2017 Aug 15.
5
Immunogenicity and protective efficacy of 3A truncated negative marker foot-and-mouth disease virus serotype A vaccine.3A 缺失标记口蹄疫病毒 A 型疫苗的免疫原性和保护效力。
Appl Microbiol Biotechnol. 2020 Mar;104(6):2589-2602. doi: 10.1007/s00253-020-10370-z. Epub 2020 Jan 30.
6
Immunogenicity of a foot-and-mouth disease (FMD) vaccine against serotypes O, A, SAT-2, and Asia-1 in the Middle East and many parts of Africa, Southeast Asia and Europe.一种口蹄疫(FMD)疫苗针对中东、非洲许多地区、东南亚和欧洲的O型、A型、SAT - 2型和亚洲1型血清型的免疫原性。
Virol J. 2025 Apr 11;22(1):98. doi: 10.1186/s12985-025-02698-7.
7
Immunity of foot-and-mouth disease serotype Asia 1 by sublingual vaccination.亚洲 1 型口蹄疫通过舌下免疫。
PLoS One. 2013 May 22;8(5):e63839. doi: 10.1371/journal.pone.0063839. Print 2013.
8
Developing Vaccines Against Foot-and-Mouth Disease: a Biotechnological Approach.开发针对口蹄疫的疫苗:一种生物技术方法。
Arch Razi Inst. 2018 Dec;73(1):1-10. doi: 10.22092/ARI.2018.114054. Epub 2017 May 15.
9
Indirect ELISA using a multi-epitope recombinant protein to detect antibodies against foot-and-mouth disease virus serotype O in pigs.使用多表位重组蛋白的间接 ELISA 检测猪口蹄疫病毒血清型 O 抗体。
J Virol Methods. 2018 Dec;262:26-31. doi: 10.1016/j.jviromet.2018.09.008. Epub 2018 Sep 19.
10
Enhanced efficacy of a multi-epitope vaccine for type A and O foot‑and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist.通过将多个表位与结核分枝杆菌肝素结合血凝素(HBHA)融合,增强了 A 型和 O 型口蹄疫病毒的多表位疫苗的效力,HBHA 是一种新型 TLR4 激动剂。
Mol Immunol. 2020 May;121:118-126. doi: 10.1016/j.molimm.2020.02.018. Epub 2020 Mar 18.

本文引用的文献

1
Global foot-and-mouth disease risk assessment based on multiple spatial analysis and ecological niche model.基于多种空间分析和生态位模型的全球口蹄疫风险评估
Vet Q. 2025 Dec;45(1):1-11. doi: 10.1080/01652176.2025.2454482. Epub 2025 Jan 21.
2
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines.灭活流感疫苗与SARS-CoV-2 mRNA疫苗同侧接种与异侧接种的随机试验。
JCI Insight. 2025 Jan 9;10(4):e187075. doi: 10.1172/jci.insight.187075.
3
A ferritin-based nanoparticle displaying a neutralizing epitope for foot-and-mouth disease virus (FMDV) confers partial protection in guinea pigs.
一种展示口蹄疫病毒中和表位的基于铁蛋白的纳米颗粒在豚鼠中赋予部分保护作用。
BMC Vet Res. 2024 Jul 6;20(1):301. doi: 10.1186/s12917-024-04159-9.
4
A recombinant multi-epitope trivalent vaccine for foot-and-mouth disease virus serotype O in pigs.猪口蹄疫病毒血清型 O 的一种重组多表位三价疫苗。
Virology. 2024 Aug;596:110103. doi: 10.1016/j.virol.2024.110103. Epub 2024 May 10.
5
Random Effects Multinomial Processing Tree Models: A Maximum Likelihood Approach.随机效应多项处理树模型:最大似然法。
Psychometrika. 2023 Sep;88(3):809-829. doi: 10.1007/s11336-023-09921-w. Epub 2023 May 29.
6
Diagnostic application of formalin fixed archived tissues for detection of foot-and-mouth disease.福尔马林固定存档组织在口蹄疫检测中的诊断应用。
J Virol Methods. 2023 Aug;318:114754. doi: 10.1016/j.jviromet.2023.114754. Epub 2023 May 23.
7
A meta-analysis: the efficacy and effectiveness of polypeptide vaccines protect pigs from foot and mouth disease.一项荟萃分析:多肽疫苗预防猪口蹄疫的效果和效力。
Sci Rep. 2022 Dec 19;12(1):21868. doi: 10.1038/s41598-022-26462-x.
8
Development and Efficacy Evaluation of a Novel Nano-Emulsion Adjuvant for a Foot-and-Mouth Disease Virus-like Particles Vaccine Based on Squalane.基于角鲨烷的口蹄疫病毒样颗粒疫苗新型纳米乳佐剂的研制与效果评价
Nanomaterials (Basel). 2022 Nov 8;12(22):3934. doi: 10.3390/nano12223934.
9
Safety & effectiveness of COVID-19 vaccines: A narrative review.新型冠状病毒肺炎疫苗的安全性和有效性:叙述性综述。
Indian J Med Res. 2022 Jan;155(1):91-104. doi: 10.4103/ijmr.IJMR_474_21.
10
Targeted FMD Vaccines for Eastern Africa: The AgResults Foot and Mouth Disease Vaccine Challenge Project.东非目标口蹄疫疫苗:AgResults 口蹄疫疫苗挑战项目。
Viruses. 2021 Sep 14;13(9):1830. doi: 10.3390/v13091830.